Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide
Creator
Zhang, Yi
Wang, Li
Wang, Liying
Wan, Min
Yu, Yongli
Chen, Jianzhu
Wang, Junzhi
Wu, Xiuli
Bao, Musheng
Dai, Li
Deng, Ping
Hu, Xiaoping
Liu, Yongjun
source
Elsevier; Medline; PMC
abstract
To develop CpG oligodeoxynucleotides (CpG ODNs) based therapy for prevention and treatment of severe acute respiratory syndrome (SARS), we selected a novel CpG ODN (BW001), which displays B-type CpG ODN structure feature at the 5′ and A-type CpG ODN structure feature at the 3′, and tested for its anti-SARS-CoV activity. We found that the supernatants of human PBMCs stimulated by BW001 significantly protected Vero cells from SARS-CoV infection. BW001 could stimulate human PBMCs and pDCs to secrete high level of IFN-α and promote human PBMCs and B cells to proliferate. Furthermore, we demonstrated that BW001 could activate CD19(+) B cells and CD56(+) NK cells in human PBMCs. In addition, BW001 could enhance NK cytotoxicity and IFN-γ secretion in human PBMCs. Together, BW001 represents a novel type of CpG ODN and may have potential for the development of treatment and prevention for SARS as well as other viral associated diseases.
has issue date
2005-11-17
(
xsd:dateTime
)
bibo:doi
10.1016/j.clim.2005.09.014
bibo:pmid
16298165
has license
no-cc
sha1sum (hex)
f1d5d3319029102a40e081a3240c092badbb7411
schema:url
https://doi.org/10.1016/j.clim.2005.09.014
resource representing a document's title
Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide
has PubMed Central identifier
PMC7110578
has PubMed identifier
16298165
schema:publication
Clin Immunol
resource representing a document's body
covid:f1d5d3319029102a40e081a3240c092badbb7411#body_text
is
schema:about
of
covid:arg/f1d5d3319029102a40e081a3240c092badbb7411
named entity 'IFN-g'
named entity 'NK cells'
named entity 'SARS'
named entity 'severe acute respiratory syndrome'
named entity 'secretion'
named entity 'cytotoxicity'
named entity 'RNA'
named entity 'China'
named entity 'VSV'
named entity 'EDTA'
named entity 'IFN-a'
named entity 'Cape Cod'
named entity 'SARS'
named entity 'CD14'
named entity 'CpG'
named entity 'secretion'
named entity 'Shanghai'
named entity 'anti-viral'
named entity 'SARS'
named entity 'etiologically'
named entity 'chemokines'
named entity 'SARS-CoV'
named entity 'CD14'
named entity 'tgt'
named entity 'IFN-a'
named entity 'VSV'
named entity 'A-type'
named entity 'CpG ODN'
named entity 'IFN-a'
named entity 'Vero E6'
named entity 'PBMCs'
named entity 'up-regulate'
named entity 'CpG ODN'
named entity 'SARS-CoV'
named entity 'PBMCs'
named entity 'EDTA'
named entity 'PBMCs'
named entity 'anti-viral'
named entity 'CpG'
named entity 'cough'
named entity 'Vero E6'
named entity 'PBMCs'
named entity 'IFN-a'
named entity 'CpG ODN'
named entity 'viral replication'
named entity 'CpG ODN'
named entity 'penicillin'
named entity 'antibiotics'
named entity 'CpG'
named entity 'HCV'
named entity 'TE buffer'
named entity 'Microtiter Plate'
named entity 'vaccines'
named entity 'CD56'
named entity 'CpG'
named entity 'Beijing'
named entity 'IFN-a'
named entity 'serum'
named entity 'pDCs'
named entity 'respiratory syncytial virus (RSV) infection'
named entity 'pDCs'
named entity 'monocytes'
named entity 'excretion'
named entity 'anti-viral'
named entity 'counts per minute'
named entity 'mice'
named entity 'cytokine'
named entity 'PBMCs'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 6
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software